ATA908598A - Verfahren zur induktion von therapeutisch wirksamen proteinen durch inkubation einer körperflüssigkeit in einer einen induktor enthaltenden spritze - Google Patents

Verfahren zur induktion von therapeutisch wirksamen proteinen durch inkubation einer körperflüssigkeit in einer einen induktor enthaltenden spritze

Info

Publication number
ATA908598A
ATA908598A AT0908598A AT908598A ATA908598A AT A908598 A ATA908598 A AT A908598A AT 0908598 A AT0908598 A AT 0908598A AT 908598 A AT908598 A AT 908598A AT A908598 A ATA908598 A AT A908598A
Authority
AT
Austria
Prior art keywords
incubing
inductor
therapeutically active
active proteins
syringe containing
Prior art date
Application number
AT0908598A
Other languages
English (en)
Other versions
AT411901B (de
Inventor
Julio Reinecke
Hans Meijer
Peter Wehling
Original Assignee
Orthogen Gentechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98109186A external-priority patent/EP0899271B1/de
Application filed by Orthogen Gentechnologie Gmbh filed Critical Orthogen Gentechnologie Gmbh
Publication of ATA908598A publication Critical patent/ATA908598A/de
Application granted granted Critical
Publication of AT411901B publication Critical patent/AT411901B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT0908598A 1997-08-16 1998-08-05 Verfahren zur induktion von therapeutisch wirksamen proteinen durch inkubation einer körperflüssigkeit in einer einen induktor enthaltenden spritze AT411901B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19735537 1997-08-16
EP98109186A EP0899271B1 (de) 1997-08-16 1998-05-20 Verfahren zur Induktion von therapeutische wirksamen Proteinen
PCT/EP1998/004866 WO1999009051A1 (de) 1997-08-16 1998-08-05 Verfahren zur induktion von therapeutisch wirksamen proteinen

Publications (2)

Publication Number Publication Date
ATA908598A true ATA908598A (de) 2003-12-15
AT411901B AT411901B (de) 2004-07-26

Family

ID=26039189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0908598A AT411901B (de) 1997-08-16 1998-08-05 Verfahren zur induktion von therapeutisch wirksamen proteinen durch inkubation einer körperflüssigkeit in einer einen induktor enthaltenden spritze

Country Status (7)

Country Link
US (2) US6623472B1 (de)
JP (1) JP4038331B2 (de)
AT (1) AT411901B (de)
AU (1) AU739517B2 (de)
CA (1) CA2301174C (de)
CH (1) CH694074A5 (de)
WO (1) WO1999009051A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127851A0 (en) 1998-12-30 1999-10-28 Applied Research Systems Inhibition of TNF activity
DE19903876B4 (de) * 1999-02-01 2006-09-28 Orthogen Gentechnologie Gmbh Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
JP4225418B2 (ja) * 2004-02-05 2009-02-18 ソニー株式会社 複合装置
US7367961B2 (en) 2004-09-10 2008-05-06 Depuy Spine, Inc. Intradiscal injection of autologous interferon
US20060057223A1 (en) * 2004-09-10 2006-03-16 Dimauro Thomas M Intradiscal production of autologous interleukin antagonist
US20060130853A1 (en) * 2004-12-21 2006-06-22 Dimauro Thomas M Ultra violet therapies for spine-related pain
US7637895B2 (en) * 2006-08-22 2009-12-29 Nalin David R System and device for medically treating an individual
US20080086111A1 (en) * 2006-10-09 2008-04-10 Medrad, Inc. Fluid delivery systems and volume metering in cell delivery
US8034014B2 (en) 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
US20080269762A1 (en) * 2007-04-25 2008-10-30 Biomet Manufacturing Corp. Method and device for repair of cartilage defects
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US8753690B2 (en) * 2008-02-27 2014-06-17 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
EP2567692B1 (de) 2008-02-27 2016-04-06 Biomet Biologics, LLC Verwendung einer Vorrichtung zur Erzeugung Interleukin-1-rezeptorantagonistreicher Lösungen
USD593801S1 (en) * 2008-05-28 2009-06-09 Bier Gear, Llc Portable drinking device
CA2757517A1 (en) 2009-04-07 2010-10-21 Velin-Pharma A/S Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
US20110052561A1 (en) 2009-08-27 2011-03-03 Biomet Biologics,LLC Osteolysis treatment
US9763875B2 (en) 2009-08-27 2017-09-19 Biomet Biologics, Llc Implantable device for production of interleukin-1 receptor antagonist
AU2010294197C9 (en) 2009-09-10 2018-09-13 Velin-Pharma A/S Method for the preparation of micro-RNA and its therapeutic application
DE202009017772U1 (de) 2009-12-10 2011-04-21 Orthogen Ag Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid
DE102010026500A1 (de) * 2010-07-07 2012-01-12 Arthrogen Gmbh Verfahren zur Herstellung von autologen Proteinen
AU2011296356B2 (en) 2010-09-03 2015-07-09 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
US9763981B2 (en) 2011-06-21 2017-09-19 Arthrogen Gmbh Method for producing autologous proteins
WO2013114359A1 (en) * 2012-01-31 2013-08-08 Estar Technologies Ltd System and method for producing interleukin receptor antagonist (ira)
USD708400S1 (en) * 2012-07-03 2014-07-01 Woodstream Corporation Hummingbird feeder
US9205110B2 (en) 2012-07-18 2015-12-08 Arthrex, Inc. Enhanced autologous growth factor production and delivery system
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
WO2015037569A1 (ja) * 2013-09-12 2015-03-19 国立大学法人 岡山大学 インターロイキン１０産生促進剤
US9833474B2 (en) 2013-11-26 2017-12-05 Biomet Biologies, LLC Methods of mediating macrophage phenotypes
WO2015085348A1 (en) * 2013-12-09 2015-06-18 Cytokine Medical Australia Pty Ltd Apparatus for producing therapeutically active proteins in blood and uses thereof
US10441635B2 (en) 2014-11-10 2019-10-15 Biomet Biologics, Llc Methods of treating pain using protein solutions
US10954483B2 (en) 2015-03-12 2021-03-23 The Trustees Of The University Of Pennsylvania System, method, and device for high-throughput, automated culturing of genetically modified organisms
US9763800B2 (en) 2015-03-18 2017-09-19 Biomet C. V. Implant configured for hammertoe and small bone fixation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960139A (en) * 1975-01-15 1976-06-01 Bailey Donald L Syringe device with means for removing contaminates when drawing blood sample
US4179832A (en) * 1976-12-29 1979-12-25 Lemelson Jerome H Inflatable displays
US4118315A (en) * 1977-04-28 1978-10-03 Nasa Water system virus detection
EP0088971B1 (de) * 1982-03-13 1985-06-19 Roche Diagnostics GmbH Vorrichtung zum Nachweis von Bakterien, Pilzen und Viren im Blut
WO1989010974A1 (en) 1988-05-11 1989-11-16 Trustees Of The Sisters Of Charity Of Australia Enzyme immunoassay system
US5151192A (en) * 1990-07-13 1992-09-29 Pall Corporation Method for removing heparin from blood or plasma
US5338312A (en) * 1992-10-02 1994-08-16 Becton, Dickinson And Company Article having multi-layered lubricant and method therefor
TW381022B (en) * 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
US5413563A (en) * 1994-05-06 1995-05-09 Sterling Winthrop Inc. Pre-filled syringe having a plunger, plunger insert and plunger rod
US5411489A (en) * 1994-05-06 1995-05-02 Sterling Winthrop Inc. Pre-filled syringe and pre-filled cartridge having actuating cylinder/plunger rod combination for reducing syringing force
US5411488A (en) * 1994-05-06 1995-05-02 Sterling Winthrop Inc. Pre-filled syringe and pre-filled cartridge having an improved plunger and plunger rod for reducing syringing force
US5710543A (en) * 1996-05-28 1998-01-20 Moore; George David Emergency warning device and method
AU719195B2 (en) * 1996-07-05 2000-05-04 Air Dimensional Design, Inc. Apparatus and method for providing large inflated undulating figures
ITVE980007U1 (it) * 1998-03-16 1999-09-16 Medici Guido Kit di illuminazione di emergenza con struttura gonfiata con aria sof fiante
CN2417368Y (zh) * 2000-01-27 2001-01-31 伟力电器股份有限公司 充气造型灯饰装置

Also Published As

Publication number Publication date
JP2001515088A (ja) 2001-09-18
JP4038331B2 (ja) 2008-01-23
US20040156823A1 (en) 2004-08-12
CH694074A5 (de) 2004-07-15
US7465293B2 (en) 2008-12-16
WO1999009051A1 (de) 1999-02-25
CA2301174C (en) 2007-11-27
AT411901B (de) 2004-07-26
CA2301174A1 (en) 1999-02-25
AU739517B2 (en) 2001-10-11
US6623472B1 (en) 2003-09-23
AU9338998A (en) 1999-03-08

Similar Documents

Publication Publication Date Title
ATA908598A (de) Verfahren zur induktion von therapeutisch wirksamen proteinen durch inkubation einer körperflüssigkeit in einer einen induktor enthaltenden spritze
DE69221828D1 (de) Verfahren zur inaktivierung von pathogenen in einer körperflüssigkeit
DE69826705D1 (de) Verfahren zur dermalen verabreichung von polypeptiden
DE69526516D1 (de) Vorrichtung zur verabreichung von peptidwirkstoffen in aerosolform
EP0785785A4 (de) Verfahren zur bekämpfung von mit neuropeptiden zusammenhängenden erkrankungen
DE59400240D1 (de) Verfahren und Vorrichtung zur Reinigung von Acrylsäure
DE59507159D1 (de) Verfahren zur magnetischen Abtrennung von Flüssigkeitskomponenten
DE69532188D1 (de) Flüssigkeit zur Beschichtung von Zähnen
DE69827434D1 (de) Verfahren zum Befüllen von Spritzen
DE69407638D1 (de) Verfahren zur Fraktionierung von Blutmaterial
DE3684613D1 (de) Verfahren zur fluessigkeitsspende.
DE69807157D1 (de) Verfahren zur Rückgewinnung von Acrylsäure
DE69522549D1 (de) Vorrichtung zur abgabe von steriler flüssigkeit
DE69403968D1 (de) Verfahren und einrichtung zur regenerierung von fluechtigen saeuren
DE69432859D1 (de) Verfahren zur reinigung von kollagenase
DE69815110D1 (de) Verfahren zur reinigung von (meth)acrylsäure
ATA124894A (de) Verfahren zur direktreduktion von eisenoxidhältigem material
DE69309624D1 (de) Verfahren zur Immobilisierung von Treibstoff
DE59804931D1 (de) Verfahren zur selektiven hydrierung von ethylenisch ungesättigten doppelbindungen in polymerisaten
DE69723995D1 (de) Vorrichtung zur iontophoretischen verabreichung von medikamenten mit verfahren zur aktivierung derselben
DE69806074D1 (de) Verfahren zur Rückgewinnung von Acrylsäure
DE59813521D1 (de) Verfahren zum polarisieren von piezoelektrischen bauelementen
DE59505524D1 (de) Verfahren zur carbonylierung von olefinen
DE59805307D1 (de) Verfahren zum verestern von (meth)acrylsäure mit einem alkanol
DE68919906D1 (de) Verfahren zum Reinigen von Methyl-Methacrylat.

Legal Events

Date Code Title Description
MM01 Lapse because of not paying annual fees

Effective date: 20151215